Cargando…

Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2

A global pandemic has emerged following the appearance of the new severe acute respiratory virus whose official name is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), strongly affecting the health sector as well as the world economy. Indeed, following the emergence of this new vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yassine, Rabhi, Makrem, Mrabet, Farhat, Fnaiech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172298/ https://www.ncbi.nlm.nih.gov/pubmed/34124259 http://dx.doi.org/10.1155/2021/6696012

Ejemplares similares

Development of a New Intelligent Joystick for People with Reduced Mobility
por: Mrabet, Makrem, et al.
Publicado: (2018)

Intelligent Control Wheelchair Using a New Visual Joystick
por: Rabhi, Yassine, et al.
Publicado: (2018)

Color edges extraction using statistical features and automatic threshold technique: application to the breast cancer cells
por: Ben Chaabane, Salim, et al.
Publicado: (2014)

Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach
por: Batool, Abida, et al.
Publicado: (2021)

Repurposing drug molecule against SARS-Cov-2 (COVID-19) through molecular docking and dynamics: a quick approach to pick FDA-approved drugs
por: Farhat, Nabeela, et al.
Publicado: (2021)

Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein
por: Sun, Chuancai, et al.
Publicado: (2021)

Unusual imaging findings of SARS‐CoV‐2 in HIV‐positive patient : A case report
por: Charifi, Yahya, et al.
Publicado: (2021)

Virtual Screening and Molecular Design of Potential SARS-COV-2 Inhibitors
por: Tinkov, O. V., et al.
Publicado: (2021)

Yeast Based Small Molecule Screen for Inhibitors of SARS-CoV
por: Frieman, Matthew, et al.
Publicado: (2011)

Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
por: Li, Shufen, et al.
Publicado: (2021)

Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis
por: Yogev, Ohad, et al.
Publicado: (2022)

Discovering small-molecule therapeutics against SARS-CoV-2
por: Tiwari, Vaibhav, et al.
Publicado: (2020)

Deep learning-based molecular dynamics simulation for structure-based drug design against SARS-CoV-2
por: Sun, Yao, et al.
Publicado: (2022)

Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling
por: Lee, Hyun, et al.
Publicado: (2019)

In silico approach for identifying natural lead molecules against SARS-COV-2
por: Gupta, Shiv Shankar, et al.
Publicado: (2021)

Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
por: Chen, Wei, et al.
Publicado: (2021)

Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection
por: Huang, Jiahao, et al.
Publicado: (2022)

Acute Adverse Effects of Vaccines Against SARS-COV-2
por: Mahmood, Amina, et al.
Publicado: (2022)

A machine learning regression model for the screening and design of potential SARS-CoV-2 protease inhibitors
por: Janairo, Gabriela Ilona B., et al.
Publicado: (2021)

Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules
por: Prasad, Ashish, et al.
Publicado: (2020)

Recent advances in developing small-molecule inhibitors against SARS-CoV-2
por: Xiang, Rong, et al.
Publicado: (2022)

From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis
por: Yogev, Ohad, et al.
Publicado: (2023)

Screening for inhibitors against SARS-CoV-2 and its variants
por: Yuan, Weijing, et al.
Publicado: (2022)

Antioxidant and protective effects of extra virgin olive oil incorporated with diallyl sulfide against CCl(4)‐induced acute liver injury in mice
por: Habibi, Emna, et al.
Publicado: (2021)

Molecule generation toward target protein (SARS-CoV-2) using reinforcement learning-based graph neural network via knowledge graph
por: Ranjan, Amit, et al.
Publicado: (2023)

To screen, or not to screen for SARS-Cov2
por: Muula, Adamson S
Publicado: (2020)

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors
por: Kim, Hoshin, et al.
Publicado: (2022)

Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach
por: Farhat, Ameny, et al.
Publicado: (2022)

Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking
por: Yu, Ran, et al.
Publicado: (2020)

Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection
por: Cui, Qi, et al.
Publicado: (2021)

Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening
por: Zhang, Li-chuan, et al.
Publicado: (2022)

Learning in Feedforward Neural Networks Accelerated by Transfer Entropy
por: Moldovan, Adrian, et al.
Publicado: (2020)

Learning in Convolutional Neural Networks Accelerated by Transfer Entropy
por: Moldovan, Adrian, et al.
Publicado: (2021)

Exploration of In-silico screening of therapeutic agents against SARS-CoV-2
por: Thakur, Yamini, et al.
Publicado: (2021)

Neural Networks in the Design of Molecules with Affinity to Selected Protein Domains
por: Nowak, Damian, et al.
Publicado: (2023)

Generative and predictive neural networks for the design of functional RNA molecules
por: Riley, Aidan T., et al.
Publicado: (2023)

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19
por: BR, Bharath, et al.
Publicado: (2020)

New Computational Approach for Peptide Vaccine Design Against SARS-COV-2
por: Biswas, Subhamoy, et al.
Publicado: (2021)

Design of Three Residues Peptides against SARS-CoV-2 Infection
por: Zannella, Carla, et al.
Publicado: (2022)

Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2
por: Ahmad, Sajjad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s340qn4f2s5tegpm9da2onio0s